Gene Therapy in Treating Patients With Cancer of The Liver

Stopped early · Phase 1

Conditions studied: Liver Cancer

In brief

Phase I trial to study the effectiveness of gene therapy with the p53 gene in treating patients who have cancer of the liver that cannot be surgically removed. Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer.

Key facts

Study ID

NCT00003147

Run by

National Cancer Institute (NCI)

People needed

30

Starts

1998-02-01

Last updated by the study team

2013-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
• University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.